Pasar al contenido principal

Resultados relacionados

Resultados totales (Incluyendo duplicados): 2
Encontrada(s) 1 página(s)

Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

NF-κB and TET2 promote macrophage reprogramming in hypoxia that overrides the immunosuppressive effects of the tumor microenvironment

  • de la Calle-Fabregat, Carlos|||0000-0002-3026-3069
  • Calafell-Segura, Josep|||0000-0002-0173-8221
  • Gardet, M.
  • Dunsmore, G.
  • Mulder, K.
  • Ciudad, Laura|||0000-0002-5219-6792
  • Silvin, A.
  • Moreno-Càceres, Joaquim|||0000-0002-4166-9419
  • Corbí, Á.L.
  • Muñoz-Pinedo, Cristina|||0000-0002-9120-664X
  • Michels, J.
  • Gouy, S.
  • Dutertre, C.A.
  • Rodríguez-Ubreva, Javier|||0000-0003-4707-4536
  • Ginhoux, F.
  • Ballestar, Esteban|||0000-0002-1400-2440
Macrophages orchestrate tissue homeostasis and immunity. In the tumor microenvironment (TME), macrophage presence is largely associated with poor prognosis because of their reprogramming into immunosuppressive cells. We investigated the effects of hypoxia, a TME-associated feature, on the functional, epigenetic, and transcriptional reprogramming of macrophages and found that hypoxia boosts their immunogenicity. Hypoxic inflammatory macrophages are characterized by a cluster of proinflammatory genes undergoing ten-eleven translocation-mediated DNA demethylation and overexpression. These genes are regulated by NF-κB, while HIF1α dominates the transcriptional reprogramming, demonstrated through ChIP-seq and pharmacological inhibition. In bladder and ovarian carcinomas, hypoxic inflammatory macrophages are enriched in immune-infiltrated tumors, correlating with better patient prognoses. Coculture assays and cell-cell communication analyses support that hypoxic-activated macrophages enhance T cell-mediated responses. The NF-κB-associated hypomethylation signature is displayed by a subset of hypoxic inflammatory macrophages, isolated from ovarian tumors. Our results challenge paradigms regarding the effects of hypoxia on macrophages and highlight actionable target cells to modulate anticancer immune responses.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

The Human Microglia Atlas (HuMicA) unravels changes in disease-associated microglia subsets across neurodegenerative conditions

  • Martins-Ferreira, Ricardo
  • Calafell-Segura, Josep|||0000-0002-0173-8221
  • Leal, Bárbara
  • Rodríguez-Ubreva, Javier|||0000-0003-4707-4536
  • Martinez-Saez, Elena|||0000-0001-6004-5364
  • Mereu, Elisabetta|||0000-0001-6101-8472
  • Pinho E Costa, Paulo|||0000-0001-6125-7000
  • Laguna, Ariadna|||0000-0002-9732-6677
  • Ballestar, Esteban|||0000-0002-1400-2440
Dysregulated microglia activation, leading to neuroinflammation, is crucial in neurodegenerative disease development and progression. We constructed an atlas of human brain immune cells by integrating nineteen single-nucleus RNA-seq and single-cell RNA-seq datasets from multiple neurodegenerative conditions, comprising 241 samples from patients with Alzheimer's disease, autism spectrum disorder, epilepsy, multiple sclerosis, Lewy body diseases, COVID-19, and healthy controls. The integrated Human Microglia Atlas (HuMicA) included 90,716 nuclei/cells and revealed nine populations distributed across all conditions. We identified four subtypes of disease-associated microglia and disease-inflammatory macrophages, recently described in mice, and shown here to be prevalent in human tissue. The high versatility of microglia is evident through changes in subset distribution across various pathologies, suggesting their contribution in shaping pathological phenotypes. A GPNMB-high subpopulation was expanded in AD and MS. In situ hybridization corroborated this increase in AD, opening the question on the relevance of this population in other pathologies. The Human Microglia Atlas includes 91,716 brain immune cells covering six neurologic pathologies. It characterizes the signatures of nine populations and describes the expansion of GPNMB-high microglia in Multiple Sclerosis and Alzheimer's Disease.